RPTPζ/phosphacan is abnormally glycosylated in a model of muscle–eye–brain disease lacking functional POMGnT1
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Congenital muscular dystrophies (CMDs) with associated brain abnormalities are a group of disorders characterized by muscular dystrophy and brain and eye abnormalities that are frequently caused by mutations in known or putative glycotransferases involved in protein O-mannosyl glycosylation. Previous work identified α-dystroglycan as the major substrate for O-mannosylation and its altered glycosylation the major cause of these disorders. However, work from several labs indicated that other proteins in the brain are also O-mannosylated and therefore could contribute to CMD pathology in patients with mutations in the protein O-mannosylation pathway, however few of these proteins have been identified and fully characterized in CMDs. In this study we identify receptor protein tyrosine phosphatase ζ (RPTPζ) and its secreted variant, phosphacan, as another potentially important substrate for protein O-mannosylation in the brain. Using a mouse model of muscle-eye-brain disease lacking functional protein O-mannose β-1,2-N-acetylglucosaminyltransferase (POMGnT1), we show that RPTPζ/phosphacan is shifted to a lower molecular weight and distinct carbohydrate epitopes normally detected on the protein are either absent or substantially reduced, including HNK-1 reactivity. The spatial and temporal expression pattern of these O-mannosylated forms of RPTPζ/phosphacan and its hypoglycosylation and loss of HNK-1 glycan epitopes in POMGnT1 knockouts are suggestive of a role in the neural phenotypes observed in patients and animal models of CMDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophies
Michele, D. E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R. D., Satz, J. S., Dollar, J., Nishino, I., Kelley, R. I., Somer, H., et al. (2002) · Nature · doi:10.1038/nature00837 · Cited by 779 · cited 5×
“Disruption of pial basement membrane integrity consequently leads to overmigration of cortical neurons and type II lissencephaly along with other CNS pathologies (Michele et al., 2002).”
BackgroundInfluentialYoshida, A., Kobayashi, K., Manya, H., Taniguchi, K., Kano, H., Mizuno, M., Inazu, T., Mitsuhashi, H., Takahashi, S., Takeuchi, M., et al. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00070-3 · Cited by 706 · cited 2×
“Exemplary to this is muscle-eye-brain disease (MEB) which arises from mutations in the gene encoding the known glycotransferase protein O-mannose β-1,2-Nacetylglucosaminyltransferase 1 (POMGnT1) (Yoshida et al., 2001, Liu et al., 2006).”
BackgroundLongman, C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg307 · Cited by 416
Composition of Perineuronal Net Extracellular Matrix in Rat Brain
Deepa, S. S., Carulli, D., Galtrey, C., Rhodes, K., Fukuda, J., Mikami, T., Sugahara, K., & Fawcett, J. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600544200 · Cited by 367
Aggrecan Glycoforms Contribute to the Molecular Heterogeneity of Perineuronal Nets
Matthews, R. T., Kelly, G. M., Zerillo, C. A., Gray, G., Tiemeyer, M., & Hockfield, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07536.2002 · Cited by 341
Self-citationO -Mannosyl Phosphorylation of Alpha-Dystroglycan Is Required for Laminin Binding
Yoshida-Moriguchi, T., Yu, L., Stalnaker, S. H., Davis, S., Kunz, S., Madson, M., Oldstone, M. B. A., Schachter, H., Wells, L., & Campbell, K. P. (2010) · Science · doi:10.1126/science.1180512 · Cited by 332
Sensory Deprivation Alters Aggrecan and Perineuronal Net Expression in the Mouse Barrel Cortex
McRae, P. A., Rocco, M. M., Kelly, G., Brumberg, J. C., & Matthews, R. T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5425-06.2007 · Cited by 272 · cited 2×
“Previous work has shown that both Cat-315 and 6B4 primarily detect carbohydrates on RPTPζ/phosphacan early in development (Dino et al., 2006; Maeda et al., 1994) and on aggrecan in the adult brain (Matthews et al., 2002, McRae et al., 2007, Saitoh et al., 2008).”
BackgroundSelf-citationNeurons Produce a Neuronal Cell Surface-Associated Chondroitin Sulfate Proteoglycan
Lander, C., Zhang, H., & Hockfield, S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00174.1998 · Cited by 107 · cited 2×
“Cat-315 has been previously characterized (Lander et al., 1998; Dino et al., 2006).”
BackgroundInfluentialHaunsø, A., Celio, M. R., Margolis, R. K., & Menoud, P.-A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01596-6 · Cited by 52 · cited 1×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Both phosphacan and aggrecan have been detected in PN structures (Haunso et al., 1999, Deepa et al., 2006), however previous work has suggested that the Cat-315 antibody primarily detects aggrecan in PNs (Matthews…”
Background
Cited by
Understanding Human Glycosylation Disorders: Biochemistry Leads the Charge
Freeze, H. H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.429274 · Cited by 213
Chondroitin sulfates and their binding molecules in the central nervous system
Djerbal, L., Lortat-Jacob, H., & Kwok, J. (2017) · Glycoconjugate Journal · doi:10.1007/s10719-017-9761-z · Cited by 144
Perineuronal net degradation in epilepsy
Rankin‐Gee, E. K., McRae, P. A., Baranov, E., Rogers, S., Wandrey, L., & Porter, B. E. (2015) · Epilepsia · doi:10.1111/epi.13026 · Cited by 100
Metadata
- Authors
- Dwyer, C. A., Baker, E., Hu, H., & Matthews, R. T.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 220
- Pages
- 47-61
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2028159558
- Cited by
- 43
- References
- 9
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: RPTPζ/phosphacan is abnormally glycosylated in a model of muscle–eye–brain disease lacking functional POMGnT1. https://app.cochat.ai/papers/10.1016/j.neuroscience.2012.06.026
- The paper
- Dwyer, C. A., Baker, E., Hu, H., & Matthews, R. T. (2012). RPTPζ/phosphacan is abnormally glycosylated in a model of muscle–eye–brain disease lacking functional POMGnT1. Neuroscience. https://doi.org/10.1016/j.neuroscience.2012.06.026
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.